Abstract
目的:观察熊果酸(UA)对肝纤维化大鼠肝组织TGF-β1基因与蛋白及α-平滑肌肌动蛋白(α-SMA)表达的影响,并探讨其抗肝纤维化作用机制。方法:SD大鼠96只随机分为正常对照组(N组1、模型组(M组)、UA低剂量组(U1组)、UA中剂量组(U2组)、UA高剂量组(U3组)及秋水仙碱组(C组),每组16只,除N组外,均用二甲基亚硝胺(Dimethvlnitrosamine,DMN)诱导肝纤维化4wk,分别给予安慰剂、不同剂量的UA、秋水仙碱腹腔注射,治疗4wk处死大鼠,取肝组织行病理HE染色及VG染色判断炎症和肝纤维化程度;分别采用免疫组织化学和Western blot检测TGF-β1蛋白和α-SMA蛋白的表达;采用RT-PCR检测TGF-β1 mRNA的表达。结果:U2和U3组肝细胞坏死和纤维组织增生明显减轻:M组TGF-β1蛋白、TGF-β1 mRNA及α-SMA蛋白较N组的表达明显增加(8.76±1.47 vs 1.48±0.24;0.60±0.11 vs 0.05±0.02;0.51±0.10 vs 0.09±0.02,均P〈0.01)。U1组和C组TGF-β1蛋白的表达较M组降低(P〈0.05),U2和U3组TGF-β1蛋白的表达较M组明显降低(5.32±1.63,3.98±0.67 vs 8.76±1.47,均P〈0.01),且低于C组的表达(7.14±1.29,P〈0.05或0.01)。U2和U3组的TGF-β1 mRNA的表达也明显低于M组(0.36±0.07,0.25±0.06 vs 0.60±0.11,均P〈0.01)和C组(0.47±0.10,P〈0.05或0.01)。U1-U3组较M组α-SMA蛋白的表达明显降低(0.36±0.08,0.23±0.02,0.15±0.03 vs 0.51±0.10,均P〈0.01);U2和U3组α-SMA蛋白的表达也显著低于C组(0.43±0.05,均P〈0.01)。结论:UA能明显改善肝纤维化大鼠的肝脏组织结构,减轻肝纤维化;其抗肝纤维化的机制可能与降低TGF-β1表达,抑制HSC的激活有关。
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.